Engineering targeted chromosomal amplifications in human breast epithelial cells

Simeon Springer, Kyung H. Yi, Jeenah Park, Anandita Rajpurohit, Amanda J. Price, Josh Lauring

Research output: Contribution to journalArticle

Abstract

Chromosomal amplifications are among the most common genetic alterations found in human cancers. However, experimental systems to study the processes that lead to specific, recurrent amplification events in human cancers are lacking. Moreover, some common amplifications, such as that at 8p11-12 in breast cancer, harbor multiple driver oncogenes, which are poorly modeled by conventional overexpression approaches. We sought to develop an experimental system to model recurrent chromosomal amplification events in human cell lines. Our strategy is to use homologous-recombination-mediated gene targeting to deliver a dominantly selectable, amplifiable marker to a specified chromosomal location. We used adeno-associated virus vectors to target human MCF-7 breast cancer cells at the ZNF703 locus, in the recurrent 8p11-12 amplicon, using the E. coli inosine monophosphate dehydrogenase (IMPDH) enzyme as a marker. We applied selective pressure using IMPDH inhibitors. Surviving clones were found to have increased copy number of ZNF703 (average 2.5-fold increase) by droplet digital PCR and FISH. Genome-wide array comparative genomic hybridization confirmed that amplifications had occurred on the short arm of chromosome 8, without changes on 8q or other chromosomes. Patterns of amplification were variable and similar to those seen in primary human breast cancers, including “sawtooth” patterns, distal copy number loss, and large continuous regions of copy number gain. This system will allow study of the cis- and trans-acting factors that are permissive for chromosomal amplification and provide a model to analyze oncogene cooperativity in amplifications harboring multiple candidate driver genes.

Original languageEnglish (US)
Pages (from-to)313-321
Number of pages9
JournalBreast Cancer Research and Treatment
Volume152
Issue number2
DOIs
StatePublished - Jun 23 2015

Fingerprint

Breast
Epithelial Cells
Inosine Monophosphate
Breast Neoplasms
Oncogenes
Oxidoreductases
Chromosomes, Human, Pair 8
Dependovirus
Comparative Genomic Hybridization
Trans-Activators
Gene Targeting
Homologous Recombination
Neoplasms
Clone Cells
Chromosomes
Genome
Escherichia coli
Cell Line
Polymerase Chain Reaction
Enzymes

Keywords

  • 8p11-12
  • Breast cancer
  • Chromosomal amplifications
  • Gene targeting
  • ZNF703

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Springer, S., Yi, K. H., Park, J., Rajpurohit, A., Price, A. J., & Lauring, J. (2015). Engineering targeted chromosomal amplifications in human breast epithelial cells. Breast Cancer Research and Treatment, 152(2), 313-321. https://doi.org/10.1007/s10549-015-3468-2

Engineering targeted chromosomal amplifications in human breast epithelial cells. / Springer, Simeon; Yi, Kyung H.; Park, Jeenah; Rajpurohit, Anandita; Price, Amanda J.; Lauring, Josh.

In: Breast Cancer Research and Treatment, Vol. 152, No. 2, 23.06.2015, p. 313-321.

Research output: Contribution to journalArticle

Springer, S, Yi, KH, Park, J, Rajpurohit, A, Price, AJ & Lauring, J 2015, 'Engineering targeted chromosomal amplifications in human breast epithelial cells', Breast Cancer Research and Treatment, vol. 152, no. 2, pp. 313-321. https://doi.org/10.1007/s10549-015-3468-2
Springer, Simeon ; Yi, Kyung H. ; Park, Jeenah ; Rajpurohit, Anandita ; Price, Amanda J. ; Lauring, Josh. / Engineering targeted chromosomal amplifications in human breast epithelial cells. In: Breast Cancer Research and Treatment. 2015 ; Vol. 152, No. 2. pp. 313-321.
@article{7f64a8489c604a35af22a061912011e2,
title = "Engineering targeted chromosomal amplifications in human breast epithelial cells",
abstract = "Chromosomal amplifications are among the most common genetic alterations found in human cancers. However, experimental systems to study the processes that lead to specific, recurrent amplification events in human cancers are lacking. Moreover, some common amplifications, such as that at 8p11-12 in breast cancer, harbor multiple driver oncogenes, which are poorly modeled by conventional overexpression approaches. We sought to develop an experimental system to model recurrent chromosomal amplification events in human cell lines. Our strategy is to use homologous-recombination-mediated gene targeting to deliver a dominantly selectable, amplifiable marker to a specified chromosomal location. We used adeno-associated virus vectors to target human MCF-7 breast cancer cells at the ZNF703 locus, in the recurrent 8p11-12 amplicon, using the E. coli inosine monophosphate dehydrogenase (IMPDH) enzyme as a marker. We applied selective pressure using IMPDH inhibitors. Surviving clones were found to have increased copy number of ZNF703 (average 2.5-fold increase) by droplet digital PCR and FISH. Genome-wide array comparative genomic hybridization confirmed that amplifications had occurred on the short arm of chromosome 8, without changes on 8q or other chromosomes. Patterns of amplification were variable and similar to those seen in primary human breast cancers, including “sawtooth” patterns, distal copy number loss, and large continuous regions of copy number gain. This system will allow study of the cis- and trans-acting factors that are permissive for chromosomal amplification and provide a model to analyze oncogene cooperativity in amplifications harboring multiple candidate driver genes.",
keywords = "8p11-12, Breast cancer, Chromosomal amplifications, Gene targeting, ZNF703",
author = "Simeon Springer and Yi, {Kyung H.} and Jeenah Park and Anandita Rajpurohit and Price, {Amanda J.} and Josh Lauring",
year = "2015",
month = "6",
day = "23",
doi = "10.1007/s10549-015-3468-2",
language = "English (US)",
volume = "152",
pages = "313--321",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Engineering targeted chromosomal amplifications in human breast epithelial cells

AU - Springer, Simeon

AU - Yi, Kyung H.

AU - Park, Jeenah

AU - Rajpurohit, Anandita

AU - Price, Amanda J.

AU - Lauring, Josh

PY - 2015/6/23

Y1 - 2015/6/23

N2 - Chromosomal amplifications are among the most common genetic alterations found in human cancers. However, experimental systems to study the processes that lead to specific, recurrent amplification events in human cancers are lacking. Moreover, some common amplifications, such as that at 8p11-12 in breast cancer, harbor multiple driver oncogenes, which are poorly modeled by conventional overexpression approaches. We sought to develop an experimental system to model recurrent chromosomal amplification events in human cell lines. Our strategy is to use homologous-recombination-mediated gene targeting to deliver a dominantly selectable, amplifiable marker to a specified chromosomal location. We used adeno-associated virus vectors to target human MCF-7 breast cancer cells at the ZNF703 locus, in the recurrent 8p11-12 amplicon, using the E. coli inosine monophosphate dehydrogenase (IMPDH) enzyme as a marker. We applied selective pressure using IMPDH inhibitors. Surviving clones were found to have increased copy number of ZNF703 (average 2.5-fold increase) by droplet digital PCR and FISH. Genome-wide array comparative genomic hybridization confirmed that amplifications had occurred on the short arm of chromosome 8, without changes on 8q or other chromosomes. Patterns of amplification were variable and similar to those seen in primary human breast cancers, including “sawtooth” patterns, distal copy number loss, and large continuous regions of copy number gain. This system will allow study of the cis- and trans-acting factors that are permissive for chromosomal amplification and provide a model to analyze oncogene cooperativity in amplifications harboring multiple candidate driver genes.

AB - Chromosomal amplifications are among the most common genetic alterations found in human cancers. However, experimental systems to study the processes that lead to specific, recurrent amplification events in human cancers are lacking. Moreover, some common amplifications, such as that at 8p11-12 in breast cancer, harbor multiple driver oncogenes, which are poorly modeled by conventional overexpression approaches. We sought to develop an experimental system to model recurrent chromosomal amplification events in human cell lines. Our strategy is to use homologous-recombination-mediated gene targeting to deliver a dominantly selectable, amplifiable marker to a specified chromosomal location. We used adeno-associated virus vectors to target human MCF-7 breast cancer cells at the ZNF703 locus, in the recurrent 8p11-12 amplicon, using the E. coli inosine monophosphate dehydrogenase (IMPDH) enzyme as a marker. We applied selective pressure using IMPDH inhibitors. Surviving clones were found to have increased copy number of ZNF703 (average 2.5-fold increase) by droplet digital PCR and FISH. Genome-wide array comparative genomic hybridization confirmed that amplifications had occurred on the short arm of chromosome 8, without changes on 8q or other chromosomes. Patterns of amplification were variable and similar to those seen in primary human breast cancers, including “sawtooth” patterns, distal copy number loss, and large continuous regions of copy number gain. This system will allow study of the cis- and trans-acting factors that are permissive for chromosomal amplification and provide a model to analyze oncogene cooperativity in amplifications harboring multiple candidate driver genes.

KW - 8p11-12

KW - Breast cancer

KW - Chromosomal amplifications

KW - Gene targeting

KW - ZNF703

UR - http://www.scopus.com/inward/record.url?scp=84946493848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946493848&partnerID=8YFLogxK

U2 - 10.1007/s10549-015-3468-2

DO - 10.1007/s10549-015-3468-2

M3 - Article

C2 - 26099605

AN - SCOPUS:84946493848

VL - 152

SP - 313

EP - 321

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -